Launching an Over-the-Counter (OTC) drug in the United States is a rigorous process, but it doesn’t always require the years-long, multi-million dollar path of a New Drug Application (NDA). For most OTC products, the pathway to market relies on the OTC Drug Monograph system. But what exactly is it, and why does your entire launch strategy depend on it?
The “Rulebook” for OTC Drugs
Think of the OTC Monograph system as a set of standards established by the FDA. Its purpose is to streamline the introduction of drug products that have well-known ingredients and a long history of safety and efficacy. Instead of requiring pre-approval for every single product, the FDA allows you to launch without an NDA, provided you strictly follow the rules laid out in the relevant monograph.
What Does a Monograph Cover?
If you are planning to launch a sunscreen, hand sanitizer, or anti-acne product, there is likely a specific monograph for that category. This document dictates:
- Active Ingredients: Which ingredients are permitted and in what specific potencies.
- Combinations: Which active ingredients can be used together.
- Testing Requirements: Specific efficacy tests, such as SPF testing for sunscreens.
- Labeling: Mandatory warnings and claims you are allowed to make.
Why It Matters
The first step in product development is to compare your product concept with the applicable monograph. If your product does not conform precisely, whether it’s the wrong dosage or an unapproved combination, the FDA considers it an “unapproved drug”. This can lead to immediate enforcement action, meaning your product could be pulled from the market before it even has a chance to succeed.
Don’t waste resources developing a product that can’t legally be sold. Start with the monograph.
Learn more about launching an OTC product the right way in our webinar!